US-based Emergent’s anthrax vaccine gets FDA clearance
HQ Team July 21, 2023: Emergent BioSolutions Inc., a US developer of vaccines for infectious diseases, announced its anthrax vaccine has been approved.
Drugs
Health
Pharma